Latest AI and machine learning research in breast cancer for healthcare professionals.
Extravasation of therapeutic radioligands such as [177Lu]Lu-PSMA-617 or [177Lu]Lu-DOTATATE is rare but may result in localized radiation injury. In the absence of standardized guidelines, management remains empirical. We describe two cases of [177Lu]Lu-PSMA extravasation, evaluated using a fully automated, time-resolved dosimetric workflow supporting evidence-based conservative management. App...
Realizing the therapeutic potential of antibodies requires simultaneously optimizing multiple properties, such as antigen-binding specificity, viscosity, clearance and immunogenicity. However, existing methods used for this task are time consuming and resource intensive, often struggling to balance these properties. Here we propose DualGPT-AB, a dual-stage conditional generative pre-trained transf...
BACKGROUND: The assessment of estrogen/progesterone receptors (ER/PR) and human epidermal growth factor receptor 2 (HER2) is essential for managing br...
BACKGROUND: Breast cancer metastasis remains a major clinical challenge due to its complex molecular mechanisms, highlighting the need to identify key...
BACKGROUND: Prognostic information is essential for decision-making in breast cancer management. In recent years, trials and clinical practice have em...
The therapeutic gain ratio (TGR) of radiotherapy for hepatocellular carcinoma (HCC) remains limited by two major barriers: insufficient precision in a...
OBJECTIVE: The increasing global demand to assess pediatric skeletal malocclusions poses a growing challenge, as current screening methods are depende...
OBJECTIVE: To understand whether cancer-neutral image attributes (breast area and number of slices) impact an AI algorithm assessment of negative digi...
PURPOSE: In this prospective cross-over study, the precision of manual correction of the clinical target volume (CTV) during online-adaptive radiother...
BACKGROUND: Implant-based reconstruction failure remains a significant complication following breast reconstruction, with substantial implications for...
Chemotherapy-induced madarosis significantly impacts patient quality of life, yet current assessment methods rely heavily on subjective grading, limit...
Neoadjuvant therapy (NAT) has emerged as a standard treatment strategy for locally advanced breast cancer (BC), yet robust biomarkers for response pre...
Digital twin technology has emerged as a transformative innovation in healthcare, offering virtual replicas of physical entities at patient-level, equ...
With global population aging and increased life expectancy, bone diseases affect a substantial proportion of individuals worldwide, imposing a signifi...
Chemotherapy response in colorectal cancer (CRC) exhibits significant heterogeneity, with current clinical predictors failing to capture complex genom...
Uveal melanoma (UM) presents a formidable clinical challenge due to its marked resistance to radiotherapy. In this study, an integrative strategy comb...
INTRODUCTION: High-grade serous carcinoma (HGSC) is the most common and aggressive subtype of ovarian cancer. Although tumour stage and complete cytor...
OBJECTIVE: Radiation-induced erectile dysfunction (RIED) is a frequent, unpredictable complication following radiotherapy for prostate cancer. We hypo...
BACKGROUND: Approximately 40% of patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), advanced br...
BACKGROUND: Response evaluation of pancreatic ductal adenocarcinoma (PDAC) with routine contrast-enhanced CT (CECT) using RECIST is currently inadequa...